Ntagi
-
{
- All
- News
-
India Should Keep Close Vigil On China's COVID-19 Rise: Covid Panel Chief
Amid the rising COVID cases in China, a top Indian health expert on Tuesday cautioned the people while asking them to keep a close vigil on the situation in the country.
-
Cervical Cancer Vaccine Could Be Developed In India by April-May 2023: Medical Panel Chief
The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country.
-
Vaccine Panel Endorses Booster Before 9 Months If Flying Abroad: Report
The NTAGI has recommended that those who need to travel overseas can take the precaution dose of Covid vaccine as required by the country they are travelling to, before the stipulated nine-month waiting period, sources told PTI.
-
COVID-19 Working Group To Review Data For Covovax Vaccine On Friday: Report
The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine - Covovax for use for children and adults, on April 1, sources said today.
-
No Consensus On Additional Doses, Jabs For Children At Top Panel Meet
At a long meeting on Monday held amid the rise of Omicron cases, the government's top vaccine advisory panel failed to arrive at a consensus on a booster dose or vaccination of children.
-
India Should Keep Close Vigil On China's COVID-19 Rise: Covid Panel Chief
Amid the rising COVID cases in China, a top Indian health expert on Tuesday cautioned the people while asking them to keep a close vigil on the situation in the country.
-
Cervical Cancer Vaccine Could Be Developed In India by April-May 2023: Medical Panel Chief
The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country.
-
Vaccine Panel Endorses Booster Before 9 Months If Flying Abroad: Report
The NTAGI has recommended that those who need to travel overseas can take the precaution dose of Covid vaccine as required by the country they are travelling to, before the stipulated nine-month waiting period, sources told PTI.
-
COVID-19 Working Group To Review Data For Covovax Vaccine On Friday: Report
The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine - Covovax for use for children and adults, on April 1, sources said today.
-
No Consensus On Additional Doses, Jabs For Children At Top Panel Meet
At a long meeting on Monday held amid the rise of Omicron cases, the government's top vaccine advisory panel failed to arrive at a consensus on a booster dose or vaccination of children.
